期刊文献+

聚乙二醇1000维生素E琥珀酸酯在纳米制剂中的应用进展 被引量:7

Recent advance in the application of D-α-tocopherol polyethylene glycol 1000 succinate for nano drug delivery systems
下载PDF
导出
摘要 目的综述聚乙二醇1000维生素E琥珀酸酯(D-α-tocopherol polyethylene glycol 1000 succi-nate,TPGS)在各种纳米制剂中的最新进展。方法查阅国内外相关文献共48篇,对这些文献进行分析、概括和总结。结果 TPGS能够提高药物包封率和细胞吸收,改善药物释放,提高药物生物利用度,并能协同起抗癌疗效。广泛应用于聚合物纳米粒、聚合物胶束、纳米脂质体、纳米药物等纳米给药系统中。结论 TPGS在纳米制剂中有着良好应用前景。 Objective To summarize the recent advances and discuss the future development of TPGS in nano drug delivery systems. Methods The related literatures and patents were consulted and the recent advances were summarized. Results TPGS could increase the drug encapsulation efficiency and cellular uptake, improve the property of drug release, enhance the drug oral bioavailability, and synergistically enhance the toxicity for cancer cells. It was widely utilized in nanometer drug delivery systems such as polymeric nanoparticles, polymeric micelles, nanometer liposomes and drug nanoparticles or nanosuspensions. Conclusions TPGS has broad prospects in nano drug delivery systems.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2012年第12期981-987,共7页 Journal of Shenyang Pharmaceutical University
关键词 聚乙二醇1000维生素E琥珀酸酯 纳米制剂 表面活性剂 D-α-tacopheryl polyethylene glycol 1000 succinate nano drug delivery systems surfactant
  • 相关文献

参考文献48

  • 1GAO Yan, LI Ling-bing, ZHAI Guang-xi. Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization camptothecin[J]. Colloid Sturface B ,2008,64 (2) :194 - 199. 被引量:1
  • 2SHIEH M J, HSU C Y, HUANG L Y. Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells[J]. J Control Release, 2011, 152(3 ) :418 -425. 被引量:1
  • 3KE W T, LIN S Y, HO H O, et al. Physical character- izations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS)as a sur- factant for the oral delivery of protein drugs[J]. J Control Release,2005,102 (2) :489 - 507. 被引量:1
  • 4REPKA M A, MCNIGITY J W. Influence of vitamin E TPGS on the properties of hydrophilic films pro- duced by hot-melt extrusion [J]. Int J Pharm, 2000, 202 ( 1/2 ) :63 - 70. 被引量:1
  • 5SHIN S C, KIM J. Physicochemical characterization of solid dispersion of furosemide with TPGS[J]. Int J Pharm,2003,251 (1/2) :79 - 84. 被引量:1
  • 6DINTAMAN J M, SILVERMAN J A. Inhibition of P- glycoprotein by D-a-tocopheryl polyethylene glycol 1000 succinate (TPGS)[J]. Pharm Res, 1999, 16 (10) :1550 - 1556. 被引量:1
  • 7FENG S S, CHIEN S. Chemotherapeutic engineering: Application and further development of chemical engi- neering principles for chemotherapy of cancer and oth-er diseases[J]. Chem Eng Sci,2003,58 (18) :4087 - 4114. 被引量:1
  • 8NISHIYAMA N, KATAOKA K. Current state, a- chievements, and future prospects of polymeric mi- celles as nanocarriers for drug and gene delivery [J]. Pharmacol Therapeut,2006,112 (3) :630 - 648. 被引量:1
  • 9TORCHILIN V P. Recent advances with liposomes as pharmaceutical carriers [ J ]. Nat Rev Drug Discov, 2005,4(2) : 145 - 160. 被引量:1
  • 10CAI S, YANG Q H, BAGBY TR, et al. Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles[J]. Adv Drug Deliver Rev, 2011, 63( 10/11 ) :901 -908. 被引量:1

二级参考文献26

  • 1张宁,魏晓慧.注射用脂质体的药学研究[J].中国新药杂志,2007,16(14):1065-1067. 被引量:2
  • 2FREDERIKSEN L, ANTON K, VAN HOOGEVEST P, et al. Preparation of liposomes encapsulating watersoluble compounds using supercritical carbon dioxide [ J]. J Pharmaceutical Sciences, 1997,86 ( 8 ) : 921 - 928. 被引量:1
  • 3MAMOT C, NGUYEN J B, POURDEHNAD M, et al. Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery [J]. J Neuro-Oncology ,2004,68 ( 1 ) : 1 - 9. 被引量:1
  • 4AFERGAN E, EPSTEIN H, DAHAN R, et al. Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes[ J]. J Cont Rel,2008,132 (2) :84-90. 被引量:1
  • 5SATO Y, KIWADA H, KATO Y, et al. Effects of dose and vesicle size on the pharmacokinetics of liposomes [J], Chem Pharm Bull, 1986,34 ( 10 ) : 4244 - 4252. 被引量:1
  • 6GARCIA-GARCIA E, ANDRIEUX K, GIL S, et al. Colloidal carriers and blood-brain barrier(BBB) translocation:Away to deliver drugsto the brain? [ J ]. Int J Pharm,2005,298(2) :274 - 292. 被引量:1
  • 7GHAGHADA K B, SAUL J, NATARAJAN J V, et al. Folate targeting of drug carriers: A mathematical model[ J ]. J Control Release, 2005,104 ( 1 ) : 113 -128. 被引量:1
  • 8YATVIN M B, WEINSTEIN J N, DENNIS W H, et al. Design of liposomes for enhanced local release of drugs by hyperthermia [J]. Science, 1978, 202: 1290 - 1293. 被引量:1
  • 9CHELVI T P, RALHAN R. Designing of thermosensitive liposomes from natural lipids for multimodality cancer therapy[J]. Int J Hyperthermia, 1995,11 ( 5 ) : 685 - 695. 被引量:1
  • 10TORCHILIN V P. Recent advances with liposomes as pharmaceutical carriers [J]. Nature Reviews Drug Discovery ,2005,4 ( 2 ) : 145 - 160. 被引量:1

共引文献22

同被引文献97

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部